Jump to content

Publication: The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial

From CAMIH
Revision as of 14:10, 9 July 2024 by JDoerfler (talk | contribs) (Created page with "{{Publication |Title=The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial |Topic=Vitamin E |Author=Shamsaei G; Ahmadzadeh A; Mehraban N |Year=2017 |Journal=Jundishapur Journal Of Natural Pharmaceutical Products |DOI=https://doi.org/10.5812/jjnpp.65027 |Authors Abstract=Background: Chemotherapy-induced neuropathy is one of the most severe complications of cancer drug therapies causing a number of proble...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Reference
Title The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial
Topic Vitamin E
Author Shamsaei G, Ahmadzadeh A, Mehraban N
Year 2017
Journal Jundishapur Journal Of Natural Pharmaceutical Products
DOI https://doi.org/10.5812/jjnpp.65027

Author's Abstract The abstract and the information and conclusions contained therein were written by the authors of the publication.

Background: Chemotherapy-induced neuropathy is one of the most severe complications of cancer drug therapies causing a number of problems for patients and making treatment limitation decisions problematic. One of the most important drugs used in breast cancer chemotherapy regimens, Taxol is considered as the most common cause of neuropathy in such cases. The aim of this study was to evaluate the effect of vitamin E on reducing the Taxol-induced neuropathy development among patients with breast cancer.

Methods: The randomized clinical trial (RCT) included 70 patients with breast cancer who received Taxol chemotherapy regimens. They were assigned to one of the two groups: a group without vitamin E feeding (Group I) and a group with vitamin E treatment at a daily dose of 400 IU bid (Group II). Electrophysiological testing of all patients was performed before starting medications and again 3 months post-treatment. The data were compared between the groups. Results: Vitamin E feeding had no significant effect on amplitude, latency, and CV of tibial and peroneal nerves (P > 0.05), while the delta amplitude of sural nerve was significantly lower among patients taking vitamin E supplements (P = 0.007). Conclusion: We suggest the inhibitory effect of vitamin E on the progression of Taxol-induced neuropathy, by slowing the speed of progression, among breast cancer patients by improving the function of the nervous system.



This publication is referenced in the following studies:

  1. Shamsaei et al. (2017): The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial